News Daily News ‘Stronger’ Evidence That High Lp(a) Concentrations Cause CVD Yael L. Maxwell December 12, 2019
News Opinion Editor's Corner ISCHEMIA Questions? Some Answers From David Maron Shelley Wood December 09, 2019
News Conference News AHA 2019 Full GALILEO Results Confirm Harm With Rivaroxaban After TAVR Todd Neale November 17, 2019
News Daily News FDA Advisors Recommend CVD Event Reduction Claim for Icosapent Ethyl Michael O'Riordan November 14, 2019
News Daily News Noninvasive Tests for Chest Pain: New Insight Into Who Benefits Most Yael L. Maxwell November 07, 2019
News Daily News Bleeding on Low-Dose Antithrombotic Therapy a ‘Red Flag’ for New Cancers Yael L. Maxwell September 20, 2019
News Conference News ESC 2019 Beta-blockers Safe, Effective for HFrEF Patients With Renal Dysfunction: Meta-analysis Yael L. Maxwell September 12, 2019
News Conference News ESC 2019 Ticagrelor Risky in Diabetic Patients With Stable CAD: THEMIS Michael O'Riordan September 01, 2019
News Conference News SCCT 2019 Chest Pain Rule-Out? For Two ED Scores, It’s a Draw Yael L. Maxwell July 19, 2019
News Conference News SCCT 2019 Doubling Down on SCOT-HEART: Mechanisms, Applicability, and Future Directions Yael L. Maxwell July 18, 2019
News Conference News SCCT 2019 CTA or Function Tests in High-risk Chest Pain and No Known CAD: Debate Goes On Yael L. Maxwell July 16, 2019
News Conference News SCCT 2019 Time to Ease Up on Prior Authorization for PCSK9 Inhibitors? Yael L. Maxwell July 15, 2019
News Daily News Most Supplements and Diets Don’t Lower CVD or Mortality Risks Michael O'Riordan July 09, 2019
News Daily News ‘People Are Pretty Optimistic’ as Renal Denervation’s Comeback Continues Todd Neale June 24, 2019
News Conference News EAS 2019 Should Lp(a) Be Measured and Treated? Two Experts Hash Out Its Current Role Michael O'Riordan June 07, 2019
News Conference News SCAI 2019 LDL Apheresis Potentially a ‘Head Start’ to Conventional Lipid-Lowering Methods Post-PCI in ACS: PREMIER Yael L. Maxwell June 03, 2019
News Conference News SCAI 2019 Cancer and CV Disease Care: What’s Known? What Lies Ahead for Cardio-Oncology? Yael L. Maxwell May 30, 2019
News Conference News EAS 2019 Clear CVD Risk Reduction With PCSK9 Inhibitors, but No Mortality Effect: Meta-analysis Michael O'Riordan May 28, 2019
News Daily News Three Years On, Absorb BVS Still Doesn’t Improve Myocardial Blood Flow Michael O'Riordan April 30, 2019